Case number 2:16-cv-00035
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 25, 2018 | 35 | Notice of Appeal* (1) |
| Jan 8, 2016 | 1 | Exhibit A (52) |
| Jan 8, 2016 | 2 | Exhibit B (52) |
| Jan 8, 2016 | 3 | Exhibit C (25) |
| Jan 8, 2016 | 4 | Exhibit D (53) |
| Jan 8, 2016 | 1 | Main Document (17) |
| Jan 8, 2016 | 2 | Corporate Disclosure Statement (2) |
| Jan 8, 2016 | 5 | Civil Cover Sheet (1) |
| Jan 8, 2016 | 1 | Exhibit A (52) |
| Jan 8, 2016 | 6 | Statement Pursuant to Local Civil Rule 10.1(a) (2) |
| Jan 8, 2016 | 2 | Exhibit B (52) |
| Jan 8, 2016 | 7 | Certification Pursuant to Local Civil Rule 11.2 (2) |
| Jan 8, 2016 | 3 | Exhibit C (25) |
| Jan 8, 2016 | 4 | Exhibit D (53) |
| Jan 8, 2016 | 5 | Civil Cover Sheet (1) |
| Jan 8, 2016 | 6 | Statement Pursuant to Local Civil Rule 10.1(a) (2) |
| Jan 8, 2016 | 7 | Certification Pursuant to Local Civil Rule 11.2 (2) |
| Jan 8, 2016 | 2 | Corporate Disclosure Statement (2) |
| Jan 8, 2016 | 1 | Main Document (17) |
| Jan 8, 2016 | 1 | Exhibit A (52) |
| Jan 8, 2016 | 2 | Exhibit B (52) |
| Jan 8, 2016 | 3 | Exhibit C (25) |
| Jan 8, 2016 | 2 | Corporate Disclosure Statement (2) |
| Jan 8, 2016 | 4 | Exhibit D (53) |
| Jan 8, 2016 | 5 | Civil Cover Sheet (1) |
| Jan 8, 2016 | 6 | Statement Pursuant to Local Civil Rule 10.1(a) (2) |
| Jan 8, 2016 | 7 | Certification Pursuant to Local Civil Rule 11.2 (2) |
| Jan 8, 2016 | 1 | Main Document (17) |
| Jan 8, 2016 | 3 | Corporate Disclosure Statement (1) |
| Jan 8, 2016 | 1 | Exhibit A (52) |
| Jan 8, 2016 | 2 | Exhibit B (52) |
| Jan 8, 2016 | 3 | Exhibit C (25) |
| Jan 8, 2016 | 4 | Exhibit D (53) |
| Jan 8, 2016 | 5 | Civil Cover Sheet (1) |
| Jan 8, 2016 | 6 | Statement Pursuant to Local Civil Rule 10.1(a) (2) |
| Jan 8, 2016 | 7 | Certification Pursuant to Local Civil Rule 11.2 (2) |
| Jan 8, 2016 | 1 | Main Document (17) |
